Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 6 Hydroxyhexanoic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103373914B reveals a breakthrough in hydroxy acid manufacturing using TS-1 catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103695486A reveals a novel one-pot enzymatic route for Atorvastatin intermediates, offering significant cost reduction and safer manufacturing for global API producers.
Patent CN104630125B reveals engineered E. coli for high-purity statin intermediate synthesis with mild conditions and reduced processing complexity.
Patent CN104498510A enables enzymatic synthesis of atorvastatin side chain with superior stereoselectivity and scalable fermentation processes for global supply chains.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.